Related Experiment Video
Updated: Aug 13, 2026

Working with Auditory HEI-OC1 Cells
Published on: September 3, 2016
Hepsin shows inhibitory effects through apoptotic pathway on ovarian cancer cell lines
Keiichiro Nakamura1, Yasutomo Nasu, Atsushi Hongo
1Department of Obstetrics and Gynecology, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Okayama 700-8558, Japan. k-nakamu@cc.okayama-u.ac.jp
Abstract:
In light of the poor prognosis for ovarian cancer patients, the research continues for innovative and efficacious treatment modalities. Along with surgical and chemotherapeutic regimens, gene therapy has emerged as one of the leading contenders in the treatment armamentarium. Hepsin is a type II transmembrane serine protease originally identified in the human liver as a cDNA clone. However, the biological function of Hepsin expression remains unclear. Apoptotic cell was increasingly common among higher proportions of Hepsin transfectants. We discovered that first-time stable transfectants of Hepsin significantly inhibited cell growth in the monolayer, anchorage-independent cell growth in the soft agar in vitro, and tumorigenicity in vivo in ovarian cancer cell lines. These results demonstrated that Hepsin has a potential therapeutic effect that inhibits through up-regulation of p53-dependent apoptosis and caspase-3, -6, and -7 activations. Our findings in this study identify Hepsin as a target for new approaches in ovarian cancer treatment.
Insights
Hepsin gene therapy shows promise for ovarian cancer treatment by inhibiting tumor growth and promoting cell death. This research identifies Hepsin as a potential therapeutic target for improving patient outcomes.
Area of Science:
- Oncology
- Molecular Biology
- Gene Therapy
Background:
- Ovarian cancer has a poor prognosis, driving the search for novel treatments beyond surgery and chemotherapy.
- Gene therapy is a promising area, with Hepsin (a serine protease) emerging as a potential therapeutic agent.
- The precise biological role of Hepsin expression in cancer remains largely uncharacterized.
Purpose of the Study:
- To investigate the therapeutic potential of Hepsin in ovarian cancer.
- To determine the effect of Hepsin expression on ovarian cancer cell growth and tumorigenicity.
- To elucidate the molecular mechanisms underlying Hepsin's anti-cancer effects.
Main Methods:
- Stable Hepsin transfectants were generated in ovarian cancer cell lines.
- In vitro assays assessed cell growth inhibition (monolayer and soft agar).
- In vivo tumorigenicity was evaluated, alongside analysis of apoptosis markers (p53, caspase-3, -6, -7).
Main Results:
- Hepsin expression significantly inhibited ovarian cancer cell growth in vitro and reduced tumorigenicity in vivo.
- Increased apoptotic cells were observed in Hepsin-expressing cells.
- Hepsin up-regulated p53-dependent apoptosis and activated caspase-3, -6, and -7.
Conclusions:
- Hepsin demonstrates significant therapeutic potential as an anti-cancer agent in ovarian cancer.
- Hepsin inhibits ovarian cancer progression by inducing apoptosis via the p53 and caspase pathways.
- Hepsin represents a novel molecular target for developing innovative ovarian cancer therapies.
Related Concept Videos
The Intrinsic Apoptotic Pathway
Inhibition of Cdk Activity
The Extrinsic Apoptotic Pathway
Interactions Between Signaling Pathways
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
